Literature DB >> 35443782

Disk Correlates for Revised Clinical and Laboratory Standards Institute Enterobacterales Piperacillin-Tazobactam MIC Breakpoints.

Romney Humphries1, Pranita D Tamma2, Amy J Mathers3.   

Abstract

Entities:  

Keywords:  CLSI; Enterobacterales; disk diffusion; piperacillin-tazobactam

Mesh：

Substances：

Year:  2022        PMID： 35443782      PMCID： PMC9116183          DOI： 10.1128/jcm.00243-22

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   11.677


× No keyword cloud information.
  6 in total

1.  Building a Better Test for Piperacillin-Tazobactam Susceptibility Testing: Would that It Were So Simple (It's Complicated).

Authors:  Andrew Henderson; Romney Humphries
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex.

Authors:  Sergio García-Fernández; Yohann Bala; Tom Armstrong; María García-Castillo; C A Burnham; Meghan A Wallace; Dwight Hardy; Gilles Zambardi; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

3.  OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli.

Authors:  David M Livermore; Michaela Day; Paul Cleary; Katie L Hopkins; Mark A Toleman; David W Wareham; Camilla Wiuff; Michel Doumith; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2019-02-01       Impact factor: 5.790

4.  Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Authors:  Patrick N A Harris; Paul A Tambyah; David C Lye; Yin Mo; Tau H Lee; Mesut Yilmaz; Thamer H Alenazi; Yaseen Arabi; Marco Falcone; Matteo Bassetti; Elda Righi; Benjamin A Rogers; Souha Kanj; Hasan Bhally; Jon Iredell; Marc Mendelson; Tom H Boyles; David Looke; Spiros Miyakis; Genevieve Walls; Mohammed Al Khamis; Ahmed Zikri; Amy Crowe; Paul Ingram; Nick Daneman; Paul Griffin; Eugene Athan; Penelope Lorenc; Peter Baker; Leah Roberts; Scott A Beatson; Anton Y Peleg; Tiffany Harris-Brown; David L Paterson
Journal:  JAMA       Date:  2018-09-11       Impact factor: 56.272

5.  Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.

Authors:  A Henderson; D L Paterson; M D Chatfield; P A Tambyah; D C Lye; P P De; R T P Lin; K L Chew; M Yin; T H Lee; M Yilmaz; R Cakmak; T H Alenazi; Y M Arabi; M Falcone; M Bassetti; E Righi; B A Rogers; S S Kanj; H Bhally; J Iredell; M Mendelson; T H Boyles; D F M Looke; N J Runnegar; S Miyakis; G Walls; M A I Khamis; A Zikri; A Crowe; P R Ingram; N Daneman; P Griffin; E Athan; L Roberts; S A Beatson; A Y Peleg; K Cottrell; M J Bauer; E Tan; K Chaw; G R Nimmo; T Harris-Brown; P N A Harris
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

6.  Variability of Beta-Lactam Broth Microdilution for Pseudomonas aeruginosa.

Authors:  A A Bhalodi; N Oppermann; S A Campeau; R M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.